Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy

Sponsor
Aristotle University Of Thessaloniki (Other)
Overall Status
Unknown status
CT.gov ID
NCT01039714
Collaborator
(none)
200
1
5
40.3

Study Details

Study Description

Brief Summary

Hypocalcemia is one of the most frequent complications of total thyroidectomy, a procedure used for benign as well as malignant conditions of the thyroid gland. Postoperative hypocalcemia is usually caused by hypoparathyroidism. Vitamin D is implicated in calcium metabolism as it increases intestinal calcium transport and regulates parathormone production. Aim of the present study is to evaluate preoperative vitamin D levels as a prognostic factor for postoperative hypocalcemia and hypoparathyroidism.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Preoperative Vitamin D Levels as a Prognostic Factor for Postoperative Hypocalcemia and Hypoparathyroidism After Total Thyroidectomy
    Study Start Date :
    Dec 1, 2009
    Anticipated Primary Completion Date :
    Apr 1, 2010
    Anticipated Study Completion Date :
    May 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    Total Thyroidectomy

    Outcome Measures

    Primary Outcome Measures

    1. Impact of preoperative vitamin D levels on postoperative hypocalcemia after total thyroidectomy. [24 hours postoperatively]

    Secondary Outcome Measures

    1. Impact of preoperative vitamin D levels on parathyroid function after total thyroidectomy. [24 hours postoperatively]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patient is over 18 years old

    2. Patient scheduled for total thyroidectomy

    3. Patient signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures

    Exclusion Criteria:
    1. Primary hyperparathyroidism

    2. Primary hypoparathyroidism

    3. Chronic Renal Failure

    4. Hypoalbuminemia

    5. Neck irradiation

    6. Systematic Diseases (e.g., infections)

    7. Thyroid or parathyroid cancer

    8. Osteoporosis

    9. Drugs that influence calcium metabolism (vitamin D analogues, oral calcium supplements, biphosphonates, teriparatide, thiazide diuretics)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 AHEPA University Hospital Thessaloniki, Greece Thessaloniki Makedonia Greece

    Sponsors and Collaborators

    • Aristotle University Of Thessaloniki

    Investigators

    • Study Director: Spyros T Papavramidis, Prof, Aristotle University Of Thessaloniki

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01039714
    Other Study ID Numbers:
    • GXKVITD1
    First Posted:
    Dec 25, 2009
    Last Update Posted:
    Dec 25, 2009
    Last Verified:
    Dec 1, 2009

    Study Results

    No Results Posted as of Dec 25, 2009